Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): Long-term results of a randomised, controlled, phase 3 trial

The Lancet Oncology

Volumn 14, Issue 12, 2013, Pages 1208-1215

  Nordlinger, Bernard ^a   Sorbye, Halfdan ^b   Glimelius, Bengt ^c   Poston, Graeme J ^d   Schlag, Peter M ^e   Rougier, Philippe ^a   Bechstein, Wolf O ^f   Primrose, John N ^g   Walpole, Euan T ^h   Finch Jones, Meg ⁱ   Jaeck, Daniel ^j   Mirza, Darius ^k   Parks, Rowan W ^l   Mauer, Murielle ^m   Tanis, Erik ⁿ   Van Cutsem, Eric ^o   Scheithauer, Werner ^p   Gruenberger, Thomas ^p  

^a HÔPITAL AMBROISE PARÉ   (France)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c UPPSALA UNIVERSITY   (Sweden)

^d UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^g SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^h UNIVERSITY OF QUEENSLAND   (Australia)

ⁱ UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST   (United Kingdom)

^j HÔPITAL DE HAUTEPIERRE   (France)

^k UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^l ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^m Statistics Department   (Belgium)

ⁿ Fellowship Programme Unit   (Belgium)

^o UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^p MEDICAL UNIVERSITY OF VIENNA   (Austria)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ADULT; ARTICLE; CANCER SURVIVAL; CAUSE OF DEATH; COLON CANCER; COLORECTAL CANCER; CONTINUOUS INFUSION; CONTROLLED STUDY; FEMALE; HUMAN; LAPAROTOMY; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PERIOPERATIVE PERIOD; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RANDOMIZED CONTROLLED TRIAL; RECTUM CANCER; RISK FACTOR; SENSITIVITY ANALYSIS; SURVIVAL TIME; TUMOR LOCALIZATION;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AUSTRALIA; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; EUROPE; FEMALE; FLUOROURACIL; HEPATECTOMY; HONG KONG; HUMANS; INTENTION TO TREAT ANALYSIS; KAPLAN-MEIER ESTIMATE; LEUCOVORIN; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; ORGANOPLATINUM COMPOUNDS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84886719568     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(13)70447-9     Document Type: Article

References (18)

1. Fong Y, Cohen AM, Fortner JG, et al. Liver resection for colorectal metastases. J Clin Oncol 1997, 15:938-946.
2. Kopetz S, Chang GJ, Overman MJ, et al. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol 2009, 27:3677-3683.
3. Fong Y Hepatic colorectal metastasis: current surgical therapy, selection criteria for hepatectomy, and role for adjuvant therapy. Adv Surg 2000, 34:351-381.
4. Fong Y, Salo J Surgical therapy of hepatic colorectal metastasis. Semin Oncol 1999, 26:514-523.
5. de Jong MC, Pulitano C, Ribero D, et al. Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis. An international multi-institutional analysis of 1669 patients. Ann Surg 2009, 250:440-448.
6. Power DG, Kemeny NE Role of adjuvant therapy after resection of colorectal cancer liver metastases. J Clin Oncol 2010, 28:2300-2309.
7. Kemeny MM, Sudeshna A, Gray B, et al. Combined modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy. An intergroup study. J Clin Oncol 2002, 20:1499-1505.
8. Lorenz M, Muller HH, Schramm H, et al. Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. Ann Surg 1998, 228:756-762.
9. Kemeny N, Huang Y, Cohen AM, et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 1999, 341:2039-2048.
10. Nordlinger B, Sorbye H, Glimelius B, et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 2008, 371:1007-1016. for the EORTC Gastro-Intestinal Tract Cancer Group, Cancer Research UKCancer Research UK, Arbeitsgruppe Lebermetastasen und-tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie (ALM-CAO)Arbeitsgruppe Lebermetastasen und-tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie (ALM-CAO), Australasian Gastro-Intestinal Trials Group (AGITG)Australasian Gastro-Intestinal Trials Group (AGITG), Fédération Francophone de Cancérologie Digestive (FFCD)Fédération Francophone de Cancérologie Digestive (FFCD).
11. Nordlinger B, Guiguet M, Vaillant JC, et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Cancer 1996, 77:1254-1262.
12. de Gramont A, Figer A, Seymour M, et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2000, 18:2938-2947.
13. Kaplan EL, Meier P Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958, 53:457-481.
14. Gray RJ A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988, 16:1141-1154.
15. André T, Boni C, Navarro M, et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol 2009, 27:3109-3116.
16. Yothers G, O'Connell MJ, Allegra CJ, et al. Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial, including survival and subset analyses. J Clin Oncol 2011, 29:3768-3774.
17. Haller DG, Tabernero J, Maroun J, et al. Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer. J Clin Oncol 2011, 29:1465-1471.
18. Mitry E, Fields AL, Bleiberg H, et al. Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials. J Clin Oncol 2008, 26:4906-4911.